124 related articles for article (PubMed ID: 423189)
1. Studies on biologically active halogenated compounds. 1. Synthesis and central nervous system depressant activity of 2-(fluoromethyl)-3-aryl-4(3H)-quinazolinone derivatives.
Tani J; Yamada Y; Oine T; Ochiai T; Ishida R; Inoue I
J Med Chem; 1979 Jan; 22(1):95-9. PubMed ID: 423189
[TBL] [Abstract][Full Text] [Related]
2. Studies on biologically active halogenated compounds. II. Chemical modifications of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone and the CNS depressant activities of related compounds.
Tani J; Yamada Y; Ochiai T; Ishida R; Inoue I; Oine T
Chem Pharm Bull (Tokyo); 1979 Nov; 27(11):2675-87. PubMed ID: 527143
[No Abstract] [Full Text] [Related]
3. Synthesis and central nervous system activity of quinazolones related to 2-methyl-3-(o-tolyl)-4(3H)-quinazolone (methaqualone).
Ager IR; Harrison DR; Kennewell PD; Taylor JB
J Med Chem; 1977 Mar; 20(3):379-86. PubMed ID: 845871
[TBL] [Abstract][Full Text] [Related]
4. Quinazolinones. 19. Communication [1]: synthesis and evaluation of some CNS depressant properties of 3-(2-[(5-aryl-1,3,4-oxadiazole-2-yl)amino]acetamido)-2-methyl-4 (3H)-quinazolinones.
Ergenç N; Büyüktimkin S; Capan G; Baktir G; Rollas S
Pharmazie; 1991 Apr; 46(4):290-1. PubMed ID: 1886919
[No Abstract] [Full Text] [Related]
5. Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones.
Wolfe JF; Rathman TL; Sleevi MC; Campbell JA; Greenwood TD
J Med Chem; 1990 Jan; 33(1):161-6. PubMed ID: 2296016
[TBL] [Abstract][Full Text] [Related]
6. [Quinazolinones. 3. Synthesis, pharmacology and structure-activity relationship of derivatives of 2-methyl-3-(4-oxo-3-phenyl-thiazolidin-2-ylidenamino)-4(3H) -quinazolinone].
Büyüktimkin S
Arch Pharm (Weinheim); 1985 Jun; 318(6):496-501. PubMed ID: 4026543
[No Abstract] [Full Text] [Related]
7. Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
Jatav V; Mishra P; Kashaw S; Stables JP
Eur J Med Chem; 2008 Jan; 43(1):135-41. PubMed ID: 17418452
[TBL] [Abstract][Full Text] [Related]
8. Syntheses and pharmacological activities of 2-heterocyclic substituted 4(3H)-quinazolinone derivatives.
Hisano T; Ichikawa M; Kito G; Nishi T
Chem Pharm Bull (Tokyo); 1972 Dec; 20(12):2575-84. PubMed ID: 4652820
[No Abstract] [Full Text] [Related]
9. Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea.
Kashaw SK; Kashaw V; Mishra P; Jain NK; Stables JP
Eur J Med Chem; 2009 Nov; 44(11):4335-43. PubMed ID: 19674817
[TBL] [Abstract][Full Text] [Related]
10. Structural and molecular modeling studies of quinazolinone anticonvulsants.
Duke NE; Codding PW
Acta Crystallogr B; 1993 Aug; 49 ( Pt 4)():719-26. PubMed ID: 8397980
[TBL] [Abstract][Full Text] [Related]
11. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
Jatav V; Mishra P; Kashaw S; Stables JP
Eur J Med Chem; 2008 Sep; 43(9):1945-54. PubMed ID: 18222569
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of some new 4(3H)-Quinazolinones as potential CNS depressants.
Chaurasia MR; Sharma SK
Arch Pharm (Weinheim); 1982 Apr; 315(4):377-81. PubMed ID: 7092515
[No Abstract] [Full Text] [Related]
13. Synthesis and CNS activities of some 2-alkyl-3(2-substituted indol-3-yl)-methyl, 6-substituted-quinazolin-4(3H)-ones.
Misra S; Satsangi RK; Tiwari SS
Pol J Pharmacol Pharm; 1982; 34(5-6):441-7. PubMed ID: 6138761
[TBL] [Abstract][Full Text] [Related]
14. Potential CNS active agents. II--Studies of 4(3H)-quinazolinones.
Lakhan R; Singh RL
Farmaco Sci; 1988 Sep; 43(9):745-51. PubMed ID: 3229498
[TBL] [Abstract][Full Text] [Related]
15. Syntheses of some new 4(3H)-quinazolinones as potential CNS active agents.
Lakhan R; Singh OP
Arch Pharm (Weinheim); 1985 Mar; 318(3):228-38. PubMed ID: 2861799
[No Abstract] [Full Text] [Related]
16. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. I. Effects on the central nervous system (author's transl)].
Ochiai T; Yamamura M; Kudo Y; Ishida R
Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):347-57. PubMed ID: 7327455
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants.
Lien EJ; Liao RC; Shinouda HG
J Pharm Sci; 1979 Apr; 68(4):463-5. PubMed ID: 438970
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticonvulsant evaluation of some new 2,3,8-trisubstituted-4(3H)-quinazoline derivatives.
El-Azab AS; Eltahir KE
Bioorg Med Chem Lett; 2012 Jan; 22(1):327-33. PubMed ID: 22137344
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of some 3-substituted-2-[(2,4-dichlorophenoxy)-methyl]quinazolin-4(3H)-one derivatives as potential anticonvulsant agents.
Abbas Sel-S; Awadallah FM; Ibrahim NA; Said EG; Kamel G
Chem Pharm Bull (Tokyo); 2013; 61(7):679-87. PubMed ID: 23812393
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system depressant effects of N3-substituted derivatives of deoxyuridine in mice.
Kimura T; Kuze J; Teraoka S; Watanabe K; Tateoka Y; Kondo S; Ho IK; Yamamoto I
Biol Pharm Bull; 1996 Jan; 19(1):142-5. PubMed ID: 8820928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
